Print Page   |   Contact Us   |   Sign In   |   Register
Community Search
CASSS Associate Directors
Share |

Our Leadership

Board of Directors

Associate Directors

Distinguished Fellows

Staff

 

    

Associate Directors (ADs) are “statutory members” of CASSS.  Membership in this committee is open to all who have participated as a volunteer on any of the CASSS meeting committees and who actively parcticipate in AD activities. In most professional societies you pay dues to join the organization.  In this way, CASSS is unique.  Our “dues” are participation instead of a monetary payment.  CASSS' ADs are a select group of members, made up of those who care enough about the organization to not just send in an annual check but actually contribute their time and expertise.  This is what gives us our strength. The ADs are also the members of CASSS charged with electing the Board and advising them on issues of importance to the membership-at-large.

 

Sid Advant, Celgene
Kris Antonsen, BioMarin Pharmaceutical, Inc.
Thomas Arroll, Seattle Genetics, Inc.
Yves Aubin, Health Canada
Sandra Auguste-Bowler, LEO Pharma A/S
Evangelos Bakopanos, Health Canada
Jared Bee, MedImmune, A member of the Astra Zeneca Group
Edna Betgovargez, AB SCIEX
Jens Bjørn Nielsen, Novo Nordisk A/S
Tim Blanc, Eli Lilly and Company

Markus Blümel, Novartis Pharma AG
Michael Boyne, Biotech Logic
Michael Brenowitz, Albert Einstein College of Medicine
Betty Burri, USDA
Greg Cantin, Five Prime Therapeutics Inc
Holly Cargill, Pfizer, Inc.
Dave Carr, Bioanalytical Technologies
James Carroll, Pfizer, Inc.
Andrew Chang, Novo Nordisk Inc.
Michael Chang, Shire Pharmaceuticals

Emmanuelle Charton, EDQM, Council of Europe
Guodong Chen, Bristol-Myers Squibb Company
Barry Cherney, Amgen Inc.
Judy Chou, Medivation, Inc.
Natalie Ciaccio, BioMarin Pharmaceutical, Inc.
David Cirelli, Pfizer, Inc.
Steve Cohen, SAC Analytical Consultants
Mary Cromwell, Genentech, a Member of the Roche Group
Bob Cunico, Pacific Bio Labs
Xiao-Ping Dai, Celgene

Francois de l'Escaille, Analis SA
Eef Dirksen, Synthon
Bharat Dixit, Genocea Biosciences, Inc.
J.R. Dobbins, Eli Lilly and Company
Vlad Dolnik, Alcor BioSeparations
Narasaiah Dontha, Celgene
Roman Drews, rEVO Biologics
Anders Dybdal Nielsen, Novo Nordisk A/S
Julia Edwards, Biogen
Bill Egan, GlaxoSmithKline

Christof Finkler, F. Hoffmann - La Roche Ltd.
Franta Foret, Institute of Analytical Chemistry ASCR, v.v.i.
Kathy Francissen, Genentech, a Member of the Roche Group
Michelle Frazier, Coherus
John Frenz 
Marta Germano, Janssen, Infectious Diseases and Vaccines
Ralf Gleixner, Tellus Life Sciences
András Guttman, University of Pannonia
Fadi Hakki, MedImmune, A member of AstraZenca Group

Jason Hampson, Amgen Inc.
Mei Han, Amgen Inc.
Stephen Hartman, AbbVie Inc.
Julie Heflin, AbbVie Inc.
John Hennessey, NovaDigm Therapeutics, Inc.
John Hobbs, Beckman Coulter (Retired)
Damian Houde, Biogen
Ping Hu, Janssen R&D, LLC
Chi-Ting Huang, CTH Analytical Consulting
Brendan Hughes, Bristol-Meyers Squibb Company

Ronald Imhoff, Janssen Biologics B.V.
Xu-Rong Jiang, MedImmune, A member of AstraZenca Group
Guifeng Jiang, Sutro Biopharma Inc.
Carmilia Jiménez Ramírez, Gilead Sciences
Ilias Jimidar, Johnson & Johnson Pharmaceutical R & D
Peter Johnson, 3M Drug Delivery Systems
Franka Kálmán, Haute Ecole Spécialisée de Suisse Occidentale
Vinaya Kapoor,
Jon Kauffman, Lancaster Labs
Maura Kibbey, United States Pharmacopeial Convention (USP)

Steffen Kiessig, F. Hoffmann-La Roche Ltd.
John Kim, Teva Pharmaceuticals
Kevin King, Pfizer, Inc.
Alistair Kippen, Ipsen
Junichi Koga, Daiichi Sankyo Co., Ltd.
Carol Krantz, Sierra Oncology
Bob Kuhn, Amgen Inc.
Joe Kutza, MedImmune, A member of the AstraZeneca Group
Nathan Lacher, Pfizer, Inc.
Tom Layloff, Supply Chain Management System

David Lee, Mersana Therapeutics
In Eui Lee, Kobe University Graduate School of Science and Technology Innovation
Kathy Lee, Eli Lilly and Company
Patsy Lewis, Seattle Genetics, Inc.
Vivian Lindo, MedImmune Limited
Aston Liu, GlaxoSmithKline
Tony Lubiniecki, Janssen R&D, LLC
Anders Lund, Genzyme Corporation
Henry Luo, Regeneron Pharmaceuticals, Inc.
Michelle Lytle, Eli Lilly and Company

Yelena Lyubarskaya, Codiak Biosciences
Mirek Macka, ACROSS, Univ. of Tasmania
Helena Madden, Biogen
Khalid Mahmood, Eli Lilly and Company
John Marino, National Institute of Standards and Technology (NIST)
Philip Marriott, Monash University
William Matousek, Regeneron Pharmaceuticals, Inc.
Noriyuki Matsumoto, JPMA
Bob Mattaliano, Genzyme, A Sanofi Company
Kimberly May, Merck & Co., Inc.

Rob McCombie, Genentech, a Member of the Roche Group
Bruce Meiklejohn, Eli Lilly and Company
David Michels, Genentech, a Member of the Roche Group
Ken Miller, MedImmune, A member of the AstraZeneca Group
Thomas Millward, Novartis
Tony Mire-Sluis, AstraZeneca
Inger Mollerup, Novo Nordisk A/S
Ed Moore, University of Illinois
Jamie Moore, Genentech, a Member of the Roche Group

Gene Murano, Consultant
Linda Narhi, Amgen Inc.
Wassim Nashabeh, F. Hoffmann - La Roche Ltd.
Shawn Novick, Seattle Genetics, Inc.
Brian Nunnally, Biogen
Julia O'Neill, Tunnell Consulting, Inc. 
Fionnuala O'Driscoll, Eli Lilly and Company
Bhavin Parekh, Eli Lilly and Company
SungAe Park,
David Passmore, Bristol-Myers Squibb Company
Joe Pesek, San Jose State University

Stefanie Pluschkell, Pfizer, Inc.
Chris Pohl, Thermo Fisher Scientific
Francis Poulin, Sanofi Biopharmaceutics Development
Lesley Redfern, Abbvie Inc.
Gang (Gary) Ren, Lawrence Berkeley National Laboratory
Daisy Richardson, Merck & Co., Inc.
Anthony Ridgway, Health Canada
Noel Rieder, Amgen Inc.
Nadine Ritter, Global Biotech Experts Collaborative, LLC
Roberto Rodriguez, Bristol-Myers Squibb Company

Sushmita (Mimi) Roy, BioMarin Pharmaceutical Inc.
Meg Ruesch, Pfizer, Inc.
Reb Russell, Bristol-Myers Squibb Company
Richard Rustandi, Merck & Co., Inc.
Michael Sadick, Catalent Pharma Solutions
Oscar Salas-Solano, Seattle Genetics, Inc.
Cari Sanger, Kantisto Separation Sciences
Mark Schenerman, MedImmune, A member of the AstraZeneca Group
John Schiel, National Institute of Standards and Technology (NIST)
Martin Schiestl, Sandoz GmbH

Timothy Schofield, GlaxoSmithKline
Thomas Schreitmueller, F. Hoffmann - La Roche Ltd.
Sally Seaver, Seaver Associates LLC
Joanne Severs, Bayer Healthcare
Karin Sewerin, BioPharmaLinx AB
Zahra Shahrokh, STC Biologics
Joe Siemiatkoski, Development Insights LLC
Satish Singh, Lonza AG
Bob Sitrin, PATH
Lance Smallshaw, UCB Biopharma sprl

Zoran Sosic, Biogen
Kannan Srinivasan, Thermo Fisher Scientific
Arne Staby, Novo Nordisk A/S
Jeff Staecker, BioPhia Consulting, Inc.
Bob Stevenson, ISC
Annie Sturgess, Bristol-Myers Squibb Company
Shelley Suggett, Bayer HealthCare
Frank Svec, Lawrence Berkeley National Laboratory
Patrick Swann, Biogen
Jonathan Sweedler, University of Illinois

Garry Takle, MMD, Merck, Sharp and Dohme
Harold Taylor, Merz Pharma BmbG & Co KGaA
Max Tejada, Gilead Sciences
Hansjoerg Toll, Sandoz GmbH
Kazuhisa Uchida, Kyowa Hakko Kirin Co., Ltd
Paul Varley, MedImmune Limited
Michael Washabaugh, Adello Biologics, LLC
Hermann Wätzig, Technical University Braunschweig
Ziping Wei, Novavax
Andy Weiskopf, Biogen

Will Weiss, Eli Lilly and Company
Jolanda Westerlaken, UCB Pharma SA
Lance Wong, Bavarian Nordic
Jason Wood, Bruker Daltonics
Phil WyattWyatt Technology Corporation
Yuan XuMerck Research Laboratories
Toyohiko Yamamoto, Asahi Kasei Pharma Corp.
Min YoungUltragenyx Pharmaceutical
Christopher YuGenetech, a Member of the Roche Group
Heidi ZhangGenentech, a Member of the Roche Group
Eike ZimmermannBoehringer Ingelheim

    

 

more Calendar

3/14/2017 » 3/17/2017
AT Europe 2017

4/3/2017 » 4/5/2017
HOS 2017

5/8/2017 » 5/9/2017
Bioassays 2017

Featured Members
Frantisek Svec, Lawrence Berkeley National LaboratoryFrantisek “Frank” Svec named the 2016 recipient of the CASSS Award for Outstanding Achievement

Membership Software Powered by YourMembership  ::  Legal